Close Menu

A Gold Star

In The Scientist, Jeff Akst writes that NIH reviewers who have participated in funding rounds since the shorter applications and new guidelines were put into place are generally happy with the changes. "I think it's an improvement over the old system, but I think there is a learning curve and until everyone recalibrates there may be a period of confusion," says Karin Rodland at the Pacific Northwest National Laboratory.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.